| Andrea Brudvik, DO | |
|
3601 W 13 Mile Rd, Royal Oak, MI 48073-6712 | |
| (248) 551-6509 | |
| Not Available |
| Full Name | Andrea Brudvik |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 18 Years |
| Location | 3601 W 13 Mile Rd, Royal Oak, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942497730 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085B0100X | Radiology - Body Imaging | 5101016874 (Michigan) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 5101016874 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Beaumont Hospital - Grosse Pointe | Grosse pointe, MI | Hospital |
| Beaumont Hospital, Troy | Troy, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beaumont Medical Group Hospital Based Services | 3072875889 | 457 |
News Archive
Agilent Technologies Inc. today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.
The Hill's Healthwatch Blog: "The House passed six health-related bills Wednesday evening, including efforts to combat Medicare fraud and dispose of unused prescription drugs." The measures were approved under suspension of the rules, "an expedited procedure that only allows for 40 minutes of debate followed by a voice vote."
A new analysis of how people prioritize their attention when determining safety and danger in busy settings, such as crossing a road, suggests that a person will pay more attention to something if they learn it is associated with danger.
Cangene Corporation today reports that it has been advised by the Biomedical Advanced Research and Development Authority, an agency within the U.S. Department of Health and Human Services, that Cangene has been eliminated from the competitive range with respect to its bid on a contract for developing a treatment for acute radiation syndrome.
› Verified 1 days ago
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134144801 PECOS PAC ID: 0547178311 Enrollment ID: O20031105000139 |
News Archive
Agilent Technologies Inc. today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.
The Hill's Healthwatch Blog: "The House passed six health-related bills Wednesday evening, including efforts to combat Medicare fraud and dispose of unused prescription drugs." The measures were approved under suspension of the rules, "an expedited procedure that only allows for 40 minutes of debate followed by a voice vote."
A new analysis of how people prioritize their attention when determining safety and danger in busy settings, such as crossing a road, suggests that a person will pay more attention to something if they learn it is associated with danger.
Cangene Corporation today reports that it has been advised by the Biomedical Advanced Research and Development Authority, an agency within the U.S. Department of Health and Human Services, that Cangene has been eliminated from the competitive range with respect to its bid on a contract for developing a treatment for acute radiation syndrome.
› Verified 1 days ago
| Entity Name | Beaumont Medical Group Hospital Based Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427567858 PECOS PAC ID: 3072875889 Enrollment ID: O20180314001796 |
News Archive
Agilent Technologies Inc. today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.
The Hill's Healthwatch Blog: "The House passed six health-related bills Wednesday evening, including efforts to combat Medicare fraud and dispose of unused prescription drugs." The measures were approved under suspension of the rules, "an expedited procedure that only allows for 40 minutes of debate followed by a voice vote."
A new analysis of how people prioritize their attention when determining safety and danger in busy settings, such as crossing a road, suggests that a person will pay more attention to something if they learn it is associated with danger.
Cangene Corporation today reports that it has been advised by the Biomedical Advanced Research and Development Authority, an agency within the U.S. Department of Health and Human Services, that Cangene has been eliminated from the competitive range with respect to its bid on a contract for developing a treatment for acute radiation syndrome.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Brudvik, DO 26901 Beaumont Blvd # 3d, Southfield, MI 48033-3849 Ph: (248) 577-9221 | Andrea Brudvik, DO 3601 W 13 Mile Rd, Royal Oak, MI 48073-6712 Ph: (248) 551-6509 |
News Archive
Agilent Technologies Inc. today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.
The Hill's Healthwatch Blog: "The House passed six health-related bills Wednesday evening, including efforts to combat Medicare fraud and dispose of unused prescription drugs." The measures were approved under suspension of the rules, "an expedited procedure that only allows for 40 minutes of debate followed by a voice vote."
A new analysis of how people prioritize their attention when determining safety and danger in busy settings, such as crossing a road, suggests that a person will pay more attention to something if they learn it is associated with danger.
Cangene Corporation today reports that it has been advised by the Biomedical Advanced Research and Development Authority, an agency within the U.S. Department of Health and Human Services, that Cangene has been eliminated from the competitive range with respect to its bid on a contract for developing a treatment for acute radiation syndrome.
› Verified 1 days ago
Terrence Metz, Radiology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-5000 | |
Christopher W Keyes, MD Radiology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-7266 | |
Stephen Hudak, Radiology Medicare: Not Enrolled in Medicare Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-6262 | |
Elias Antypas, Radiology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-6509 | |
Dr. Derek Alexander Mumaw, MD Radiology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-6347 | |
Kent Donovan, Radiology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-6509 | |
Dr. John Douglas Ebersole, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-6064 |